Is It Premature to Accept Radiographic Progression-Free Survival as a Surrogate End Point in Metastatic Hormone-Sensitive Prostate Cancer?

J Clin Oncol

Jorge A. Garcia, MD, FACP, Division of Solid Tumor Oncology, UH Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH; and Daniel E. Spratt, MD, Department of Radiation Oncology, UH Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH.

Published: August 2024

Download full-text PDF	Source
http://dx.doi.org/10.1200/JCO.24.00210	DOI Listing

Publication Analysis

premature accept

accept radiographic

radiographic progression-free

progression-free survival

survival surrogate

surrogate point

point metastatic

metastatic hormone-sensitive

hormone-sensitive prostate

prostate cancer?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!